共 10 条
- [1] 7th International EFR Congress. Surgical Congress: Multidisciplinary Treatment of Colorectal Cancer, Vienna, Austria, April 28–30, 2011 European Surgery, 2011, 43 : 1 - 36
- [2] 7th International EFR Congress. Surgical Congress: Multidisciplinary Treatment of Colorectal Cancer, Vienna, Austria, April 28-30, 2011EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2011, 43 : 2 - 36不详
- [4] 11,28-BIS(CHLOROACETYL)-6,7,9,10,12,13,15,16,23,24,26,27,29,30,32,33-HEXADECAHYDRO-DIBENZO[B,Q][1,4,7,10,16,19,22,25,13,28]OCTAOXADIAZACYCLOTRIACONTINEACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1990, 46 : 1464 - 1467ANELLI, PLSTODDART, JFSLAWIN, AMZWILLIAMS, DJ
- [5] PURINE NUCLEOSIDES .28. SYNTHESIS OF 7-(2'-DEOXY-ALPHA- AND BETA-D-RIBOFURANOSYL)PURINES FROM 2'-DEOXYRIBOFURANOSYLIMIDAZOLES - PREPARATION OF 2'-DEOXY DERIVATIVE OF NUCLEOSIDE FROM PSEUDOVITAMIN-B12 FACTOR-GJOURNAL OF HETEROCYCLIC CHEMISTRY, 1970, 7 (02) : 367 - &ROUSSEAU, RJROBINS, RKTOWNSEND, LB
- [6] CRYSTAL-STRUCTURES OF COMPLEXES BETWEEN ALKALI-METAL SALTS AND CYCLIC POLYETHERS .10. COMPLEX FORMED BETWEEN 6,7,9,10,12,13,15,16,-23,24,26,27,29,30,32,33-HEXADECAHYDRODIBENZO[B,Q][1,4,7,10,13,16,19,22,-25,28]DECAOXACYCLOTRIACONTIN (DIBENZO-30-CROWN-10) AND 2 MOLECULES OF SODIUM ISOTHIOCYANATEJOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1979, (11): : 1831 - 1835OWEN, JDTRUTER, MR
- [8] Oligoether-Substituted Derivatives of Carbon-Rich 1,4,7,10,13,16-Hexaethynyltribenzo[ a , e , i ]cyclododeca-5,11,17-triyne (C 36 H 12 ) and 1,4,9,12-Tetrakis(ethynyl)dibenzo[ a , g ]cyclododeca-5,7,13,15-tetrayne (C 28 H 8 ): Potential Precursors to the Circular [6]Phenylene ('Antikekulene') FrameSYNTHESIS-STUTTGART, 2020, 52 (08): : 1287 - 1300Dahlmann, UweVollhardt, K. Peter C.
- [9] Rechtsschutz gegen die Streichung eines stofflichen Medizinproduktes aus der Übersicht der verordnungsfähigen Medizinprodukte in Anl. V der AM-RL des G-BA GG Art. 3 Abs. 1; SGB V §§31 Abs. 1 S. 2, 34 Abs. 6, 92 Abs. 1 S. 2 Nr. 6, 12 Abs. 1; VerfO G-BA Kapitel 4, §§7 Abs. 4, 38, 39, 40; AM-RL G-BA §§28, 29 Medizinrecht, 2018, 36 (8) : 609 - 619